Rauwolfia Preparation: Uses, Side Effects, and Safety
Rauwolfia Preparation is a plant-derived medicine containing alkaloids from Rauwolfia serpentina, including reserpine. It is mainly used to treat high blood pressure, although reserpine can cause significant side effects and other medicines are now often preferred. Use it only as prescribed and under regular medical supervision.
Rauwolfia Preparation can lower blood pressure but may cause drowsiness, depression, and other important side effects. Take it only at the dose prescribed and discuss your other medicines with your doctor or pharmacist.
Key facts at a glance
- RxNorm
- 78678
- Generic
- Rauwolfia Preparation
- Class
- unclassified
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- oral
- Forms
- tablet
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 31, 2026. · Read our editorial policy